Spinal muscular atrophy (SMA) is characterised by degeneration of anterior horn cells of the spinal cord and represents the second most common, lethal, autosomal recessive disorder after cystic fibrosis.
Recently, two genes have been found to be associated with SMA. The survival motor neurone gene (SMN) is an SMA determining gene as it is absent in 98-6% of patients. A second gene, XS2G3, or the highly homologous neuronal apoptosis inhibitory protein gene (NAIP) have been found to be more frequently deleted in type I than in the milder forms (types II and III). We investigated the correlation between the clinical phenotype and the genotype at these loci. A total of 106 patients were classified into type I (44), type II (31), and type III (31) and analysed using SMN, markers C212 and C272, and NAIP mapping upstream and downstream from SMN respectively. The combined analysis of all markers showed that a large proportion of type I patients (43%) carried deletions of both SMN and its flanking markers (C212/ C272 and NAIP exon 5), as compared with none of the patients with type II or III SMA. The presence oflarge scale deletions involving these loci is specific to WerdnigHoffmann disease (type I) and allows one to predict the severity of the disease in our series. (J Med Genet 1996;33:281-283) Hoffmann disease, can be recognised at birth or within 6 months of age. The children are unable to sit unaided and respiratory involvement is usually responsible for death before 2 years of age. In type II SMA, the intermediate form, children are able to sit but unable to stand or walk unaided, and they live beyond 2 years of age. In type III SMA, the mildest form known as Kugelberg-Welander disease, children have an onset after the second year of life and the course of the disease is usually chronic.
The underlying biochemical defect remains unknown. Linkage analysis has been used to localise the disease gene. All three forms map to chromosome 5q13.3, suggesting that they are the result of allelic mutations.7-l0 The genomic region encompassing the disease gene is particularly unstable and prone to large scale deletions.'1 Two genes associated with SMA have been identified in this region. The neuronal apoptosis inhibitory protein (NAIP) gene and the highly homologous gene XS2G3 have been found to be more frequently deleted in type I (45%) than in the milder forms (types II and III, 18%).1214 The survival motor neurone (SMN) gene was either absent or interrupted in the majority of patients (98 6%), independent of the type of SMA.'5 Moreover, the observation of intragenic mutations in three patients retaining the gene supported the view that SMN is the SMA determining gene. '5 We have compared clinical data from a group of 106 unrelated SMA patients with their genotype using the SMN and NAIP genes, and markers C212 and C272. Here, we show that large scale deletions involving these loci are specific to Werdnig-Hoffmann disease. figure) . Similar results were obtained with marker C212 ( figure) . The heterozygosity deficiency has been previously 
